The genetic vulnerability to cisplatin ototoxicity: a systematic review

Ototoxicity is one of the major side-effects of platinum-based chemotherapy, in particular cisplatin (cis-diammine dichloroplatinum II). To our knowledge, no systematic review has previously provided a quantitative summary estimate of the impact of genetics upon the risk of developing hearing loss....

Descripción completa

Detalles Bibliográficos
Autores principales: Tserga, Evangelia, Nandwani, Tara, Edvall, Niklas K., Bulla, Jan, Patel, Poulam, Canlon, Barbara, Cederroth, Christopher R., Baguley, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6401165/
https://www.ncbi.nlm.nih.gov/pubmed/30837596
http://dx.doi.org/10.1038/s41598-019-40138-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6401165/
https://www.ncbi.nlm.nih.gov/pubmed/30837596
http://dx.doi.org/10.1038/s41598-019-40138-z

Ejemplares similares